News – Endpoints News

Astellas licenses Claudin18.2 ADC from China’s Evopoint Biosciences

1 hour ago

Supreme Court to keep mulling state PBM dispute as US urges justices to decline case

5 hours ago

The preventive care rebrand

7 hours ago

Eisai, Merck stave off generic competition to blockbuster cancer drug Lenvima

8 hours ago

Large pharma companies spell out reasons why tariffs will harm US investments

8 hours ago

Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff

9 hours ago

Intellia reports case of liver toxicity in ATTR gene editing study

10 hours ago

Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestone

11 hours ago

DNA giant Illumina spawned an ecosystem of competitors and customers

12 hours ago

Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss

12 hours ago

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

13 hours ago

Oric locks down cash for Phase 3 prostate cancer trial with early data in hand

13 hours ago

PepGen ditches Duchenne programs after mid-stage fail, switches to previously halted muscle wasting therapy

14 hours ago

Exclusive: Movement disorder biotech Vima steps onto scene with $60M

15 hours ago

Updated: Trump administration halts more than $750M in funds for Moderna’s bird flu vaccine

Yesterday

The fate of Moderna’s next-gen Covid shot looms large after a flurry of policy changes

Yesterday

Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

Yesterday

Insurance startup Devoted Health cuts 5% of workers in small layoff

Yesterday

GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars

Yesterday

Weeks after TIGIT fail, iTeos decides to wind down

Yesterday

Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight

Yesterday

A new dawn for psychedelics? Compass could be the first to find out

Yesterday

Post-Hoc Live: Is biotech sentiment really as bad as it seems?

Yesterday

Strand Therapeutics reports promising start for mRNA cancer therapy

Yesterday

12 3 4 Next page Last page